Recro Pharma, Inc. – NASDAQ:REPH

Recro Pharma stock price today

$2.09
Financial Health
0
1
2
3
4
5
6
7
8
9

Recro Pharma stock price monthly change

+28.22%
month

Recro Pharma stock price quarterly change

+33.12%
quarter

Recro Pharma stock price yearly change

-35.09%
year

Recro Pharma key metrics

Market Cap
 177.42M
Enterprise value
 114.64M
P/E
 -8.03
EV/Sales
 1.29
EV/EBITDA
 12.89
Price/Sales
 1.34
Price/Book
 3.36
PEG ratio
 -0.09
EPS
 N/A
Revenue
 94.63M
EBITDA
 -12.84M
Income
 -13.27M
Revenue Q/Q
 14.16%
Revenue Y/Y
 4.90%
Profit margin
 -14.81%
Oper. margin
 0.86%
Gross margin
 25.94%
EBIT margin
 0.86%
EBITDA margin
 -13.57%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Recro Pharma stock price history

Recro Pharma stock forecast

Recro Pharma financial statements

Profit Margin

Recro Pharma, Inc. (NASDAQ:REPH): Profit margin
Mar 2023 21.52M -4.68M -21.76%
Jun 2023 21.79M -3.21M -14.73%
Sep 2023 23.59M -4.59M -19.47%
Dec 2023 27.71M -786K -2.84%
REPH income statement history

Quarterly Earnings

Recro Pharma, Inc. (NASDAQ:REPH): Earnings per share (EPS)
2021-11-09 -0.05 -0.07
2022-03-01 -0.07 -0.04
REPH earnings history

Debt to Assets

Recro Pharma, Inc. (NASDAQ:REPH): Debt to assets
Dec 2022 157443000 97.58M 61.98%
Mar 2023 149938000 93.96M 62.67%
Sep 2023 151530000 93.27M 61.55%
Dec 2023 153474000 94.81M 61.78%
REPH balance sheet history

Cash Flow

Recro Pharma, Inc. (NASDAQ:REPH): Cash Flow
Dec 2022 1.99M -2.73M 4.16M
Mar 2023 -2.85M -3.37M -2.47M
Sep 2023 0 0 0
Dec 2023 -146K -2.12M 655K
REPH cash flow history

Recro Pharma alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Recro Pharma
Employees

Recro Pharma, Inc. (NASDAQ:REPH): Employee count
Aug 2023 185
Sep 2023 185
Oct 2023 185
Nov 2023 185
Dec 2023 185
Jan 2024 185
Feb 2024 185
Mar 2024 185
Apr 2024 185
May 2024 185
Jun 2024 185
Jul 2024 185

Recro Pharma other data

Recro Pharma
Insider Trading

Recro Pharma, Inc. (NASDAQ:REPH): Insider trades (number of shares)
Period Buy Sel
Sep 2022 714 0
Oct 2022 625 0
Nov 2022 660 0
Apr 2023 0 370000
Aug 2023 12902222 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
CANT ELENA director
 Common Stock 30,000 $0.4 $12,000
Purchase
CHURCHILL WINSTON J director
 Common Stock 62,500 $0.4 $25,000
Purchase
ASHTON WILLIAM director
 Common Stock 22,222 $0.46 $10,111
Purchase
ENLOE J DAVID JR director, officer.. Common Stock 125,000 $0.4 $50,000
Purchase
REASONS BRYAN M. director Common Stock 62,500 $0.4 $25,000
Purchase
WEISMAN WAYNE director
 Common Stock 62,500 $0.4 $25,000
Purchase
MILLER JAMES CHARLES director
 Common Stock 37,500 $0.4 $15,000
Purchase
AWM INVESTMENT COMPANY, INC. 10 percent owner
 Common Stock 140,000 $0.4 $56,000
Purchase
AWM INVESTMENT COMPANY, INC. 10 percent owner
 Warrants 4,860,000 N/A N/A
Purchase
ARENS MATHEW PAUL director, 10 percent owner:
Pre-Funded Warrant (right to buy) 1,250,000 N/A N/A
REPH insider trading transactions

Recro Pharma
Patents

Patent
Application
Filling date: 10 Jul 2019 Issue date: 21 May 2020
Application
Filling date: 25 Aug 2019 Issue date: 19 Dec 2019
Grant
Filling date: 21 Feb 2017 Issue date: 12 Nov 2019
Grant
Filling date: 11 Apr 2018 Issue date: 5 Nov 2019
Application
Filling date: 8 Mar 2019 Issue date: 12 Sep 2019
Application
Filling date: 8 Mar 2019 Issue date: 12 Sep 2019
REPH patents

Recro Pharma
Earnings Call Transcripts

Quarter Transcript
Q4 2021 1 Mar 2022 Q4 2021 Earnings Call Transcript
Q3 2021 10 Nov 2021 Q3 2021 Earnings Call Transcript
Q2 2021 9 Aug 2021 Q2 2021 Earnings Call Transcript
Q1 2021 9 May 2021 Q1 2021 Earnings Call Transcript
REPH earnings call transcripts

Recro Pharma
Latest News

Tuesday, 1 March 2022
Seeking Alpha
Tuesday, 22 February 2022
GlobeNewsWire
Monday, 3 January 2022
GlobeNewsWire
Wednesday, 8 December 2021
Zacks Investment Research
Wednesday, 10 November 2021
Seeking Alpha
Wednesday, 20 October 2021
Benzinga
Wednesday, 6 October 2021
GlobeNewsWire
Friday, 1 October 2021
Zacks Investment Research
Thursday, 16 September 2021
Zacks Investment Research
Tuesday, 17 August 2021
GlobeNewsWire
Friday, 13 August 2021
GlobeNewsWire

Frequently Asked Questions (FAQ)

  • What's the price of Recro Pharma stock today?

    One share of Recro Pharma stock can currently be purchased for approximately $2.09.

  • When is Recro Pharma's next earnings date?

    Unfortunately, Recro Pharma's (REPH) next earnings date is currently unknown.

  • Does Recro Pharma pay dividends?

    No, Recro Pharma does not pay dividends.

  • How much money does Recro Pharma make?

    Recro Pharma has a market capitalization of 177.42M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.9% to 94.64M US dollars. Recro Pharma made a loss 13.27M US dollars in net income (profit) last year or -$0.04 on an earnings per share basis.

  • What is Recro Pharma's stock symbol?

    Recro Pharma, Inc. is traded on the NASDAQ under the ticker symbol "REPH".

  • What is Recro Pharma's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Recro Pharma?

    Shares of Recro Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Recro Pharma's key executives?

    Recro Pharma's management team includes the following people:

    • Mr. Ryan D. Lake Chief Financial Officer(age: 48, pay: $379,300)
    • Mr. J. David Enloe Jr. Pres, Chief Executive Officer & Director(age: 61, pay: $255,530)

  • How many employees does Recro Pharma have?

    As Jul 2024, Recro Pharma employs 185 workers.

  • When Recro Pharma went public?

    Recro Pharma, Inc. is publicly traded company for more then 11 years since IPO on 7 Mar 2014.

  • What is Recro Pharma's official website?

    The official website for Recro Pharma is recrocdmo.com.

  • Where are Recro Pharma's headquarters?

    Recro Pharma is headquartered at 490 Lapp Rd, Malvern, PENNSYLVANIA.

  • How can i contact Recro Pharma?

    Recro Pharma's mailing address is 490 Lapp Rd, Malvern, PENNSYLVANIA and company can be reached via phone at +1 484 395 2400.

Recro Pharma company profile:

Recro Pharma, Inc.

recrocdmo.com
Exchange:

NASDAQ

Full time employees:

185

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

+1 484 395 2400
490 Lapp Rd
Malvern, PENNSYLVANIA 19341

CIK: 0001588972
ISIN: US75629F1093
CUSIP: 75629F109